It looks like you're offline.
Open Library logo
additional options menu

MARC record from Internet Archive

LEADER: 09426cam 2200985 a 4500
001 ocm19129868
003 OCoLC
005 20151221144237.0
008 890104s1989 paua b 001 0 eng
010 $a 88033612
040 $aDNLM/DLC$beng$cDLC$dOCL$dNLM$dUKM$dMUQ$dBAKER$dBTCTA$dYDXCP$dOCLCG$dG8V$dIBC$dGTA$dGBVCP$dOCLCQ$dOCLCO
015 $aGB9011177$2bnb
016 7 $a8900502$2DNLM
016 7 $a080-36900$2uk
019 $a18992152$a21077200
020 $a0803690088
020 $a9780803690080
035 $a(OCoLC)19129868$z(OCoLC)18992152$z(OCoLC)21077200
043 $an-us---
050 00 $aRC1230$b.W33 1989
060 00 $aW1$bCO769MPED v.2 1989
060 10 $aQT 260$bW123D 1989
082 00 $a362.2/9$219
084 $a44.39$2bcl
084 $a44.70$2bcl
088 $a88033612
100 1 $aWadler, Gary I.,$d1939-
245 10 $aDrugs and the athlete /$cGary I. Wadler, Brian Hainline.
260 $aPhiladelphia :$bF.A. Davis Co.,$c©1989.
300 $axxii, 353 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aContemporary exercise and sports medicine series
504 $aIncludes bibliographical references and index.
505 0 $apt. I, Foundations of drug abuse in sports: -- Introduction: Historical perspectives; Epidemiologic approaches; Education, testing, and treatment; Categories of drugs used in sports; Evaluating drugs used in sports; Contributing factors -- Antecedents: Who is at risk?; Age; Genetics; Family factors (nongenetic); Peers; Education; Mental health -- The athlete: Entering competitive sports; The elite athlete-'the privileged few'; Stress; Performance and stress; Performance and physical factors; Performance and drug abuse; The athlete and non-performance-related drug abuse.
505 0 $apt. II, Drugs of abuse in sports: -- Anabolic steroids: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Human growth hormone: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; final note -- Amphetamine: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Cocaine: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Phenylpropanolamine, ephedrine, and the 'look-alikes': History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Caffeine: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Barbiturates and benzodiazepines: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Alcohol: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Tobacco: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Marijuana: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Narcotics: History; Chemistry and physiology; Clinical pharmacology; Use in sports; Adverse effects; Final note -- Miscellaneous: Beta blockers; Diuretics; Nonsteroidal anti-inflammatory drugs; Vitamins and minerals; Amino acids and protein; Carnitine; Bicarbonate doping; Analgesic injections; Phosphate loading -- Blood doping and erythropoietin: History; Physiology; Use in sports; Adverse effects; Final note.
505 0 $apt. III, Recognition and management of drug abuse in the athlete: -- Recognition: Introduction; Definitions; Who is at risk?; Suspecting the drug abuser; The team/sports medicine physician and the interview process; Staging of 'recreational' drug abuse; Formalized screening instruments; Final note -- Drug testing: Introduction; Intent of testing; Who shall be tested?; Which sports organizations drug test athletes and what are their policies?; Legal issues; Written policy; Selection of body fluid or tissue; The laboratory; Legal defensibility; Other considerations; Drug testing methodology and implications for the athlete; Drug testing and therapeutic drugs -- Management: Introduction; Who should be treated?; Objectives and goals of treatment; Predictors of treatment success; Selecting treatment approaches; Treatment approaches; Relapse and recovery; The athlete -- Legal considerations: Prologue; The privacy rights of athletes; Justifying invasions of athlete's privacy; Team physicians and drug use by athletes; Constraining drug use in sports; -- Epilogue.
505 0 $aAppendices: -- International Olympic Charter against doping in sport -- U.S. Olympic Committee Division of Sports Medicine and Science Drug Education & Control Policy, 1988 -- International Amateur Athletic Federation (IAAF) Doping Control Regulations, 1986 -- The NCAA Drug-Testing Program, 1988-1989 -- American College of Sports Medicine Position Stands -- Drug policies of major sports organizations: Drug policy of Major League Baseball, 1988; Drug policy of the National Basketball Association, 1988; Drug policy of the National Football League, 1988; Drug policy of the National Hockey League (Letter, March 14, 1988); United States Powerlifting Federation Drug Control Program, 1988; Drug policy of the National Association for Stock Car Auto Racing, 1988; Drug policy of the international Tennis Federation, 1988; Drug policy of the Men's Tennis Council, 1988.
520 $aThis book presents a comprehensive, balanced, well-researched, yet candid overview of one of the saddest and most unsavory topics of our time. Sad is the tale, because it sets out the enormity of a blight that is damaging or destroying the lives of increasing numbers of young persons. Unsavory it has become, because it necessarily implicates either the neglect or willful greed of trainers, managers, owners, university powers, and media purveyors who have exploited sports for their own small gains with little or no regard for the well-being or fulfillment of the athletes. Chemical shortcuts designed to enhance the athletic prowness, dissolve the tensions, or sharpen the ecstasy of the performer probably have seduced athletes for as long as peaceful physical competition has existed. Today, the drugs have become harder and exert commensurately more devastating permanent effects on the players as the epidemic enlarges and the wide-range of available drugs assume an increasing capacity to enslave- even to kill- their takers. This book describes in detail the scope of the problem, the affected number of athletes, the many substances abused, and the difficulties in treating what has become an international scandal. -- from Foreword.
650 0 $aDoping in sports.
650 0 $aDoping in sports$xTesting.
650 0 $aDoping in sports$xMoral and ethical aspects.
650 0 $aDoping in sports$xTreatment.
650 0 $aDoping in sports$zUnited States.
650 0 $aDoping in sports$xLaw and legislation$zUnited States.
650 0 $aSports$xCorrupt practices.
650 0 $aDoping in sports$xHealth aspects.
650 0 $aDoping in sports$xPhysiological effect.
650 0 $aAnabolic steroids$xHealth aspects.
650 0 $aAthletes$xDrug use.
650 1 $aAthletes$xDrug use.
650 2 $aDoping in Sports.
650 2 $aSubstance-Related Disorders$xdiagnosis.
650 6 $aDopage dans les sports.
653 $aSports$aDrug abuse
700 1 $aHainline, Brian,$d1955-
776 08 $iOnline version:$aWadler, Gary I., 1939-$tDrugs and the athlete.$dPhiladelphia : F.A. Davis Co., ©1989$w(OCoLC)581376574
830 0 $aContemporary exercise and sports medicine series.
856 41 $3Table of contents$uhttp://www.gbv.de/dms/bs/toc/026964902.pdf
938 $aBaker & Taylor$bBKTY$c49.00$d49.00$i0803690088$n0001580822$sactive
938 $aBaker and Taylor$bBTCP$n88033612 //r90
938 $aYBP Library Services$bYANK$n662399
952 $a19129868$zDLC$dURI$hFull$iLCC$jNLM$kDDC$nSummary$tContents$u20150319
952 $a224245560$zCLS$bHARVARD UNIV, CABOT SCI LIBR$dURI$hFull$iLCC$jNLM$nSummary$tContents$u20140917
952 $a231128306$zHMS$bHARVARD UNIV, MED SCH, COUNTWAY LIBR$dURI$hFull$iLCC$jNLM$nSummary$tContents$u20140917
952 $a134857255$zRBN$bBROWN UNIV$hFull$iLCC$jNLM$kDDC$u20100625
952 $a242401619$zHLS$bHARVARD UNIV, HARVARD COL LIBR$dURI$hFull$iLCC$jNLM$nSummary$tContents$u20140917
952 $a875388645$zZYU$bNEW YORK UNIV$hFull$iLCC$jNLM$kDDC$u20140402
952 $a176551293$zPUL$bPRINCETON UNIV$hFull$iLCC$jNLM$kDDC$u20100803
952 $a132441352$zJTC$bSHASTA PUB LIBR$hFull$iLCC$jNLM$kDDC$u20100726
952 $a253616654$zVVT$bCOLUMBIA UNIV, TEACHERS COL$hFull$iLCC$jNLM$kDDC$u20100725
952 $a689721337$zYUM$bYALE UNIV MED LIBR$dURI$hFull$iLCC$jNLM$kDDC$u20130322
952 $a188330393$zPAU$bUNIV OF PENNSYLVANIA$hFull$iLCC$jNLM$kDDC$u20100729
952 $a471814979$zTEU$bTEMPLE UNIV$hOther$u20100709
029 1 $aAU@$b000006211625
029 1 $aGBVCP$b026964902
029 1 $aHR0$b0803690088
029 1 $aNLM$b8900502
029 1 $aNZ1$b4973440
029 1 $aUNITY$b038234742
029 1 $aYDXCP$b662399
029 1 $aZWZ$b021006261
994 $aZ0$bPMR
948 $hNO HOLDINGS IN PMR - 1077 OTHER HOLDINGS